Despite precision medicine's promise and multimillion-dollar federal investments, the development and implementation of it in routine clinical care continue to be slow. How can we translate theory into practice? Join Dana Goldman, director of the Schaeffer Center, in conversation with John Carpten, professor and chair of translational genomics at Keck School of Medicine of USC, and Jennifer Malin, senior medical director of oncology and genetics at United Healthcare, for a webinar focused on how we can incentivize and accelerate the use of precision medicines to benefit more patients.

This webinar is part of a four-part series on precision medicine. Funding for this project was made possible in part by a grant from the Agency for Healthcare Research and Quality (AHRQ) (1R13HS026821-01). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.